BlueWind Revi™ was crafted with the patient and the physicians who treat UUI in mind. Our advanced battery-free implant allows for the device to be miniature in size without the need for replacement surgeries due to battery depletion, lead migration, or lead fracture. Our innovative external wearable technology powers the implant for a patient-centric approach to therapy allowing for increases in energy and stimulation sessions based on the patients’ needs, giving you the flexibility to ensure the best possible outcome.
In the OASIS study Completers analysis (N=139) at 12 months, Revi demonstrated:
- 95% of patients were satisfied with the treatment
- 82% of patients had a less than or equal to 50% reduction in UUI episodes
- 50% of patients were dry at 12 months on 3 consecutive days
For more information on the clinical outcomes, visit:
https://bluewindmedical.com/providers/clinical-outcomes/
